Keratoconus Treatment Clinical Study: Enrollment Deadline Ends Soon!

Written By Jonna Kieler

In the video above, Michael W. Belin, MD, Chief Medical Officer of Epion Therapeutics, discusses why he feels EpiSmart™ Epi-on corneal cross-linking may be the next major advance in the treatment of keratoconus. An Epion Clinical Study is currently underway, but there are limited spots available for patient participation in the EpiSmart™ Epi-on corneal cross-linking study. We urge you to enroll your patients in the clinical study today!

Jonna Kieler
Previous

What Is Research Telling Us About CXL in KC?
Next

IKA 2024: Importance of early diagnostics and pediatric screening of keratoconus